The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation (original) (raw)

Abstract

1. Release of the tachykinin, substance P, from the peripheral terminals of polymodal afferent C-fibres is thought to be largely responsible for the vasodilatation and plasma protein extravasation described as neurogenic inflammation. The effects of CP-96,345, a non-peptide antagonist at the substance P (NK1) receptor, on these vascular reactions were investigated in the rat. 2. Intravenously (i.v.) injected CP-96,345 (0.4-3.0 mumol kg-1) prevented the drop in blood pressure, a measure of the peripheral vasodilatation, evoked by substance P and neurokinin A in a dose- and time-dependent manner, but did not affect that elicited by the non-tachykinin peptides calcitonin gene-related peptide and vasoactive intestinal polypeptide. 3. Plasma protein extravasation evoked by i.a. infusion of substance P, antidromic stimulation of the saphenous or the vagus nerve, and stimulation of cutaneous afferent nerves with mustard oil, were each significantly inhibited by CP-96,345 (3.0-9.0 mumol kg-1, i.v.). Furthermore, CP-96,345 was orally active in blocking mustard oil-induced plasma extravasation with an ED50 of 10 mumol kg-1. 4. The inhibition of substance P-induced vasodilatation and of neurogenic plasma extravasation by CP-96,345 was stereospecific as the inactive isomer CP-96,344 (2R, 3R enantiomer of CP-96,345) had no effect. 5. Thus CP-96,345 is a specific, highly potent, long-acting and orally active inhibitor of tachykinin-mediated neurogenic inflammation.

527

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J., Chung K. F., Page C. P. Inflammatory mediators and asthma. Pharmacol Rev. 1988 Mar;40(1):49–84. [PubMed] [Google Scholar]
  2. Brain S. D., Williams T. J. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol. 1985 Dec;86(4):855–860. doi: 10.1111/j.1476-5381.1985.tb11107.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gamse R., Saria A. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide. Eur J Pharmacol. 1985 Aug 7;114(1):61–66. doi: 10.1016/0014-2999(85)90520-5. [DOI] [PubMed] [Google Scholar]
  4. Holzer P., Livingston E. H., Saria A., Guth P. H. Sensory neurons mediate protective vasodilatation in rat gastric mucosa. Am J Physiol. 1991 Mar;260(3 Pt 1):G363–G370. doi: 10.1152/ajpgi.1991.260.3.G363. [DOI] [PubMed] [Google Scholar]
  5. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 1988 Mar;24(3):739–768. doi: 10.1016/0306-4522(88)90064-4. [DOI] [PubMed] [Google Scholar]
  6. Hua X., Lundberg J. M., Theodorsson-Norheim E., Brodin E. Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins. Naunyn Schmiedebergs Arch Pharmacol. 1984 Dec;328(2):196–201. doi: 10.1007/BF00512072. [DOI] [PubMed] [Google Scholar]
  7. Lappe R. W., Todt J. A., Wendt R. L. Regional vasodilator actions of calcitonin gene-related peptide in conscious SHR. Peptides. 1987 Jul-Aug;8(4):747–749. doi: 10.1016/0196-9781(87)90052-0. [DOI] [PubMed] [Google Scholar]
  8. Lembeck F., Donnerer J., Barthó L. Inhibition of neurogenic vasodilation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]enkephalinamide. Eur J Pharmacol. 1982 Nov 19;85(2):171–176. doi: 10.1016/0014-2999(82)90462-9. [DOI] [PubMed] [Google Scholar]
  9. Lembeck F., Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(2):175–183. doi: 10.1007/BF00500282. [DOI] [PubMed] [Google Scholar]
  10. Lembeck F. The 1988 Ulf Euler Lecture. Substancce P: from extract to excitement. Acta Physiol Scand. 1988 Aug;133(4):435–454. doi: 10.1111/j.1748-1716.1988.tb08427.x. [DOI] [PubMed] [Google Scholar]
  11. Lundberg J. M., Saria A., Brodin E., Rosell S., Folkers K. A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci U S A. 1983 Feb;80(4):1120–1124. doi: 10.1073/pnas.80.4.1120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lundberg J. M., Saria A. Capsaicin-sensitive vagal neurons involved in control of vascular permeability in rat trachea. Acta Physiol Scand. 1982 Aug;115(4):521–523. doi: 10.1111/j.1748-1716.1982.tb07116.x. [DOI] [PubMed] [Google Scholar]
  13. Lundberg J. M., Saria A. Polypeptide-containing neurons in airway smooth muscle. Annu Rev Physiol. 1987;49:557–572. doi: 10.1146/annurev.ph.49.030187.003013. [DOI] [PubMed] [Google Scholar]
  14. Maggi C. A., Giuliani S., Ballati L., Lecci A., Manzini S., Patacchini R., Renzetti A. R., Rovero P., Quartara L., Giachetti A. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376. J Pharmacol Exp Ther. 1991 Jun;257(3):1172–1178. [PubMed] [Google Scholar]
  15. Maggi C. A., Giuliani S., Santicioli P., Regoli D., Meli A. Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors. J Auton Pharmacol. 1987 Mar;7(1):11–32. doi: 10.1111/j.1474-8673.1987.tb00130.x. [DOI] [PubMed] [Google Scholar]
  16. McLean S., Ganong A. H., Seeger T. F., Bryce D. K., Pratt K. G., Reynolds L. S., Siok C. J., Lowe J. A., 3rd, Heym J. Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist. Science. 1991 Jan 25;251(4992):437–439. doi: 10.1126/science.1703324. [DOI] [PubMed] [Google Scholar]
  17. Rouissi N., Gitter B. D., Waters D. C., Howbert J. J., Nixon J. A., Regoli D. Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P. Biochem Biophys Res Commun. 1991 Apr 30;176(2):894–901. doi: 10.1016/s0006-291x(05)80270-0. [DOI] [PubMed] [Google Scholar]
  18. Said S. I., Mutt V. Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature. 1970 Feb 28;225(5235):863–864. doi: 10.1038/225863a0. [DOI] [PubMed] [Google Scholar]
  19. Snider R. M., Constantine J. W., Lowe J. A., 3rd, Longo K. P., Lebel W. S., Woody H. A., Drozda S. E., Desai M. C., Vinick F. J., Spencer R. W. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science. 1991 Jan 25;251(4992):435–437. doi: 10.1126/science.1703323. [DOI] [PubMed] [Google Scholar]
  20. Xu X. J., Hao J. X., Wiesenfeld-Hallin Z., Håkanson R., Folkers K., Hökfelt T. Spantide II, a novel tachykinin antagonist, and galanin inhibit plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw. Neuroscience. 1991;42(3):731–737. doi: 10.1016/0306-4522(91)90041-l. [DOI] [PubMed] [Google Scholar]